Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Esomeprazole (40mg) Injection
Therapeutic Category
Gastroenterology, General and OTC medicines
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
40mg
Price
₹177/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Esoable 40 Injection is a sterile formulation containing esomeprazole, a proton pump inhibitor (PPI) that effectively reduces gastric acid production. This injectable medication is primarily indicated for the management of conditions associated with excessive stomach acid, such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and for the prevention of gastric ulcers in patients at risk due to prolonged NSAID therapy. By inhibiting the proton pump in the gastric parietal cells, Esoable helps to alleviate symptoms like heartburn, acid regurgitation, and discomfort associated with acid-related disorders.
The injection is particularly beneficial for patients who are unable to take oral medications due to surgical procedures or gastrointestinal issues. Esomeprazole is known for its rapid onset of action and its ability to maintain efficacy over an extended period.
Possible side effects may include headache, nausea, diarrhea, abdominal pain, and dizziness. In rare cases, serious side effects such as allergic reactions or kidney issues may occur. For optimal efficacy, Esoable 40 Injection should be stored at room temperature, protected from light, and kept out of reach of children. The reconstituted solution should be used promptly and any unused portions should be discarded in accordance with local regulations.
Management of GERD, Zollinger-Ellison syndrome, and prevention of gastric ulcers in high-risk patients.
Administer under the supervision of a healthcare professional; not recommended for self-administration. In summary, Esoable 40 Injection offers a reliable and effective option for managing acid-related disorders, ensuring rapid relief for patients who require intravenous therapy. As with any medication, patient monitoring is crucial to manage potential side effects and ensure optimal therapeutic outcomes.
Store at room temperature, protected from light.
Composition : Ondansetron (2mg) + Ranitidine (25mg)
Composition : Rabeprazole I.P. 20mg
Composition : Domperidone (10mg) + Omeprazole (20mg) in Strip Packing of 15 Tablets
Composition : Domperidone (10mg) + Pantoprazole (40mg)
Composition : Domperidone (10mg) + Rabeprazole (20mg)
Composition : Domperidone (20mg) + Domperidone (10mg) + Esomeprazole (40mg)
Composition : Domperidone (30mg) + Pantoprazole (40mg)
Composition : Domperidone (30mg) + Rabeprazole (20mg)
Composition : Esomeprazole (40mg)
Composition : Esomeprazole (E.C.) I.P. 40mg + Domperidone (S.R.) I.P. 30mg Capsules
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Esomeprazole 40mg Injection is a hospital-grade proton pump inhibitor used for severe acidity and stress-related gastric conditions, making it a strong injectable product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent hospital demand in ICU care, gastroenterology wards, emergency acidity management, upper GI bleeding support therapy, and patients who cannot take oral medication. It is commonly used in critical care and post-operative settings.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Esomeprazole 40mg Injection with monopoly rights, sterile quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital procurement, ICU usage, surgical recovery demand, and repeat institutional orders in gastro and critical care segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this injectable gastro formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.